DE000BAY0017
DE000BAY0017
Bayer AG N
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 43B EUR | 47.56B EUR | 38.69B EUR | 36.36B EUR |
Enterprise Value | 76.47B EUR | 43.27B EUR | 32.96B EUR | 66.14B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 9.05x | -- | -- | -- |
Price to Sales | 0.95x | 1.05x | 0.86x | 1.14x |
Price to Book | 1.45x | 1.61x | 1.34x | 1.4x |
EV/Revenue | 1.69x | 0.95x | 0.73x | 2.08x |
EV/EBITDA | 7.55x | 9.36x | 11.19x | -- |
Price to FCF (P/FCF) | 6.55x | 22.89x | 14.65x | 7.5x |
EV/FCF | 11.65x | 20.82x | 12.48x | 13.65x |
FCF Yield | 15.26% | 4.37% | 6.83% | 13.33% |